Literature DB >> 10091782

Low p27 expression correlates with poor prognosis for patients with oral tongue squamous cell carcinoma.

H Mineta1, K Miura, I Suzuki, S Takebayashi, H Amano, K Araki, H Harada, K Ichimura, J P Wennerberg, M R Dictor.   

Abstract

BACKGROUND: p27, a cyclin-dependent kinase inhibitor, regulates progression from G1 to S phase. There have been a few clinical reports of low p27 expression associated with poor survival among patients with cancer; however, there have been no reports of such an association in cases of head and neck cancer. The authors investigated whether p27 expression in patients with oral tongue squamous cell carcinoma was associated with their prognosis.
METHODS: Ninety-four patients with oral tongue squamous cell carcinoma were analyzed. The authors performed p27 immunohistochemistry on all patients and Western blot analysis on 19 available patients. Cox proportional hazards regression analysis that included gender, history of smoking and alcohol usage, presence of multiple primary cancers, stage, histologic grade, and p27 status was used to identify the multivariate predictive value of prognostic factors.
RESULTS: Twenty-six patients had high p27 expression (> or =50% tumor cell nuclei positive), and 68 patients had low p27 expression (<50%) by immunohistochemistry. In those with low p27 expression, N(+) and advanced T (T3 or T4) were significantly higher than in those with high p27 expression (P = 0.02 and 0.04). The 5-year survival rate in the low p27 group was 44%, whereas that in the high p27 group was 68%, indicating a significant difference (P = 0.04). p27 expression was inferred from Western blot analysis, and an arbitrary quantity (<1, 1-5, or > or =5) from the ratio of tumor to normal tissue density was used to characterize, resulting in 8 (42%), 3 (16%), and 8 (42%) patients in the low (<1-fold), intermediate (1-5-fold), and high (> or =5-fold) groups, respectively. Results of immunohistochemical analysis for p27 were significantly correlated with those of Western blot analysis (P = 0.02). Multivariate analysis revealed that low intensity of p27 expression and advanced stage (Stage III or IV) were predictors of reduced survival (P = 0.02 and 0.001).
CONCLUSIONS: Low p27 expression was associated with increasing lymph node metastasis and stage of tumor and resulted in a poor prognosis for patients with oral tongue squamous cell carcinoma. p27 is apparently a significant predictor of survival.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10091782     DOI: 10.1002/(sici)1097-0142(19990301)85:5<1011::aid-cncr1>3.0.co;2-0

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  19 in total

Review 1.  Clinico-prognostic value of D-type cyclins and p27 in laryngeal cancer patients: a review.

Authors:  L Pignataro; G Sambataro; D Pagani; G Pruneri
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-04       Impact factor: 2.124

2.  Expression and clinical significance of p27kip1 protein in primary liver cancer.

Authors:  Guangjun Shi; Peng Yang; Xiaoping Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

3.  CCN5/WISP-2 promotes growth arrest of triple-negative breast cancer cells through accumulation and trafficking of p27(Kip1) via Skp2 and FOXO3a regulation.

Authors:  I Haque; S Banerjee; A De; G Maity; S Sarkar; M Majumdar; S S Jha; D McGragor; S K Banerjee
Journal:  Oncogene       Date:  2014-08-18       Impact factor: 9.867

4.  Antitumor bioactivity of adenovirus-mediated p27mt in colorectal cancer cell line SW480.

Authors:  Ze-Qun Sun; Chang-Sheng Deng; Shao-Yong Xu; Yong Du
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

5.  Galanin receptor subtype 2 suppresses cell proliferation and induces apoptosis in p53 mutant head and neck cancer cells.

Authors:  Takeharu Kanazawa; Pavan K Kommareddi; Toshihide Iwashita; Bhavna Kumar; Kiyoshi Misawa; Yuki Misawa; Ilwhan Jang; Thankam S Nair; Yukiko Iino; Thomas E Carey
Journal:  Clin Cancer Res       Date:  2009-03-10       Impact factor: 12.531

6.  Activation of the insulin-like growth factor-1 receptor alters p27 regulation by the epidermal growth factor receptor in oral squamous carcinoma cells.

Authors:  Mark J Jameson; Linnea E Taniguchi; Kyle K VanKoevering; Menachem M Stuart; Christian R Francom; Rolando E Mendez; Andrew D Beckler; Hans T Carlson; Christopher Y Thomas; Ashraf A Khalil
Journal:  J Oral Pathol Med       Date:  2012-10-26       Impact factor: 4.253

7.  Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation.

Authors:  Carlos le Sage; Remco Nagel; David A Egan; Mariette Schrier; Elly Mesman; Annunziato Mangiola; Corrado Anile; Giulio Maira; Neri Mercatelli; Silvia Anna Ciafrè; Maria Giulia Farace; Reuven Agami
Journal:  EMBO J       Date:  2007-07-12       Impact factor: 11.598

8.  Combination of genetic variants in cyclin D1 and retinoblastoma genes predict clinical outcome in oral cancer patients.

Authors:  Abitha Murali; Bipin T Varghese; R Rejnish Kumar; S Kannan
Journal:  Tumour Biol       Date:  2015-10-12

Review 9.  Designing biomarker studies for head and neck cancer.

Authors:  Kelly Y Kim; Lisa M McShane; Barbara A Conley
Journal:  Head Neck       Date:  2014-07       Impact factor: 3.147

10.  Genetic variants of p27 and p21 as predictors for risk of second primary malignancy in patients with index squamous cell carcinoma of head and neck.

Authors:  Zhongqiu Wang; Erich M Sturgis; Fenghua Zhang; Dapeng Lei; Zhensheng Liu; Li Xu; Xicheng Song; Qingyi Wei; Guojun Li
Journal:  Mol Cancer       Date:  2012-03-26       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.